Today news
Donald Trump
Donald John Trump (born June 14, 1946) is the 45th and current president of the United States. Before entering politics, he was a businessman and television personality. Trump was born and raised in Queens, a borough of New York City, and received a bachelor's degree in economics from the Wharton School. He took charge of his family's real-estate business in 1971, renamed it The Trump Organization, and expanded its operations from Queens and Brooklyn into Manhattan. The company built or renovated skyscrapers, hotels, casinos, and golf courses. Trump later started various side ventures, mostly by licensing his name. He bought the Miss Universe brand of beauty pageants in 1996, and sold it in 2015. He produced and hosted The Apprentice, a reality television series, from 2003 to 2015. As of 2020, Forbes estimated his net worth to be $2.1 billion.[
The same in other media
Usa Maryland Virus reports Usa Maryland

Curing HIV?

Reading now: 570

AGT CEO Jeff Galvan American Gene Technologies prepares for Phase 2 trials of a treatment that may eliminate HIV from the body DAVID TAFFET | Senior Staff Maryland-based gene therapy company has completed Phase 1 trials on a cure for HIV/AIDS and is preparing to submit protocols to the Food and Drug Administration for Phase 2.

According to American Gene Technologies, “The trial hit two major benchmarks — proving that its treatment is safe and durable.” “We want to use cutting-edge gene therapies to find cures, not treatments,” said AGT CEO Jeff Galvin in a press release. “We want to disrupt the pharmaceutical industry and replace existing, expensive Big Pharma symptomatic treatments.

We want to revolutionize healthcare.” When a T-cell product that has been taken from a person infected with HIV is modified with the company’s AGT 103, the trial showed it was tolerated well and that these enhanced T-cells persist and are ready to respond to the HIV virus.

The activated T-cells are grown in a protease inhibitor to prevent any residual HIV from replicating. The trial’s first goal concerned safety of the product in high and low doses.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News